急性心肌梗死所致的恶性心律失常、泵衰竭是造成基层医院急性心肌梗死患者早期死亡的主要原因。随着血管紧张素转换酶抑制剂的早期应用,急性心肌梗死的恶性心律失常发生率明显降低,并很好地改善了左心功能,防止左室重塑[1],但此类药物所致顽固刺激干咳在国人发生率高达50%以上[2],限制了此类药物广泛临床应用。本文应用缬沙坦代替血管紧张素转换酶抑制剂,亦取得了很好的疗效,并发现缬沙坦对不同部 Malignant arrhythmia caused by acute myocardial infarction, pump failure is the primary cause of early death in patients with acute myocardial infarction in primary hospitals. With the early application of angiotensin-converting enzyme inhibitors, the incidence of malignant arrhythmias in acute myocardial infarction is significantly reduced, and left ventricular function is well improved, preventing left ventricular remodeling [1], but such drugs Stubborn stimulation of dry cough in people as high as 50% [2], limiting the wide range of clinical applications of such drugs. In this paper, valsartan instead of angiotensin converting enzyme inhibitors, but also achieved good results, and found that valsartan on the different ministries